Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Breast Cancer Management During the COVID-19 Pandemic: the Radiation Oncology Perspective

Breast Cancer Management During the COVID-19 Pandemic: the Radiation Oncology Perspective Purpose of ReviewThe coronavirus disease 19 (COVID-19) pandemic has caused disruption in healthcare throughout the world. The limitations placed on hospital resources and the need to limit potential exposure to SARS-CoV-2 for both patients and healthcare staff have affected oncologic care for patients with breast cancer (BC), including radiation therapy (RT). This review highlights published guidelines regarding the provision of radiotherapy for BC patients and their adoption by radiation oncology centers.Recent FindingsMultiple international and national consortiums plus select institutions have published formal recommendations regarding radiation therapy for BC during the COVID-19 pandemic. They embody the principles of limiting in-person visits, proper triage, and the judicious use of delay, abbreviation, or omission of RT as appropriate.SummarySince the start of the pandemic, multiple publications have provided guidance regarding RT for BC during this challenging time. The pandemic has led to increased use of telemedicine and abbreviated radiation therapy courses in the setting of BC, which are likely to persist. Future research is needed to establish the effect of these changes on oncologic outcomes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

Breast Cancer Management During the COVID-19 Pandemic: the Radiation Oncology Perspective

Current Breast Cancer Reports , Volume 14 (1) – Mar 1, 2022

Loading next page...
 
/lp/springer-journals/breast-cancer-management-during-the-covid-19-pandemic-the-radiation-Q7tccP1YVg

References (44)

Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-022-00441-7
Publisher site
See Article on Publisher Site

Abstract

Purpose of ReviewThe coronavirus disease 19 (COVID-19) pandemic has caused disruption in healthcare throughout the world. The limitations placed on hospital resources and the need to limit potential exposure to SARS-CoV-2 for both patients and healthcare staff have affected oncologic care for patients with breast cancer (BC), including radiation therapy (RT). This review highlights published guidelines regarding the provision of radiotherapy for BC patients and their adoption by radiation oncology centers.Recent FindingsMultiple international and national consortiums plus select institutions have published formal recommendations regarding radiation therapy for BC during the COVID-19 pandemic. They embody the principles of limiting in-person visits, proper triage, and the judicious use of delay, abbreviation, or omission of RT as appropriate.SummarySince the start of the pandemic, multiple publications have provided guidance regarding RT for BC during this challenging time. The pandemic has led to increased use of telemedicine and abbreviated radiation therapy courses in the setting of BC, which are likely to persist. Future research is needed to establish the effect of these changes on oncologic outcomes.

Journal

Current Breast Cancer ReportsSpringer Journals

Published: Mar 1, 2022

Keywords: Breast cancer; Radiation therapy; Hypofractionation; COVID-19

There are no references for this article.